Category Archives: Framingham Massachusetts

Eficacia y seguridad del tratamiento con anacetrapib en el tratamiento de pacientes con alto riesgo de cardiopatía isquémica

Posted on March 1, 2011 by

Image via Wikipedia Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM Jr. et al. Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. N Engl J Med 2010; 363: 2406-2415.   … Continue reading →

Posted in Anacetrapib, Cholesterol, Framingham, Framingham Massachusetts, Gram per litre, High-density lipoprotein, Low-density lipoprotein, New England Journal of Medicine | 1 Comment